PRODUCT LIST - API’S
SLN Pharmachem has a vision to develop a source under one roof for various intermediates of APIs. More focus would be to make new molecules to serve industry and stand as an excellent source of intermediates. Research ability of SLN Pharmachem has resulted in building many attractive intermediates as a part of product list. More research efforts to strengthen difficult reactions and more focus on developing new technologies will ensure us delivering new molecules of intermediates and APIs.
|4||Clomifene Citrate / Clomiphene Citrate||50-41-9|
|9||Warfarin Sodium Amorphous ( Under Development )||129-06-6|
|10||Warfarin Sodium Crystalline Clathrate||129-06-6|
|IMPORTANT NOTE- EVERY TRANSACTION IS CARRIED OUT IN CONFORMITY WITH PATENT LAWS APPLICABLE IN THE IMPORTERS OR END USERS COUNTRY AND IMPORTER OR END USER WILL BE RESPONSIBLE WITH RESPECT TO PATENT LAW IN THEIR COUNTRY. RESPONSIBILITY WITH RESPECT TO THIRD PARTYS PATENT RIGHTS IN A SPECIFIC COUNTRY LIES EXCLUSIVELY WITH BUYER.|